Home > Publications database > HAPLN1 potentiates peritoneal metastasis in pancreatic cancer. > print

001     275610
005     20240229154943.0
024 7 _ |a 10.1038/s41467-023-38064-w
|2 doi
024 7 _ |a pmid:37095087
|2 pmid
024 7 _ |a altmetric:146482228
|2 altmetric
037 _ _ |a DKFZ-2023-00816
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Wiedmann, Lena
|0 P:(DE-He78)b27922c32bcdf07ca4d5f13ecdcfd100
|b 0
|e First author
|u dkfz
245 _ _ |a HAPLN1 potentiates peritoneal metastasis in pancreatic cancer.
260 _ _ |a [London]
|c 2023
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1682491776_25680
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:A270#LA:A270#
520 _ _ |a Pancreatic ductal adenocarcinoma (PDAC) frequently metastasizes into the peritoneum, which contributes to poor prognosis. Metastatic spreading is promoted by cancer cell plasticity, yet its regulation by the microenvironment is incompletely understood. Here, we show that the presence of hyaluronan and proteoglycan link protein-1 (HAPLN1) in the extracellular matrix enhances tumor cell plasticity and PDAC metastasis. Bioinformatic analysis showed that HAPLN1 expression is enriched in the basal PDAC subtype and associated with worse overall patient survival. In a mouse model for peritoneal carcinomatosis, HAPLN1-induced immunomodulation favors a more permissive microenvironment, which accelerates the peritoneal spread of tumor cells. Mechanistically, HAPLN1, via upregulation of tumor necrosis factor receptor 2 (TNFR2), promotes TNF-mediated upregulation of Hyaluronan (HA) production, facilitating EMT, stemness, invasion and immunomodulation. Extracellular HAPLN1 modifies cancer cells and fibroblasts, rendering them more immunomodulatory. As such, we identify HAPLN1 as a prognostic marker and as a driver for peritoneal metastasis in PDAC.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a De Angelis Rigotti, Francesca
|0 P:(DE-He78)95d56cbcb8b1bb5783526d136049e3df
|b 1
|e First author
700 1 _ |a Vaquero-Siguero, Nuria
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Donato, Elisa
|0 P:(DE-He78)b3e23abb6bede16f11543cc21ae0feeb
|b 3
|u dkfz
700 1 _ |a Espinet, Elisa
|0 0000-0002-0690-9878
|b 4
700 1 _ |a Moll, Iris
|0 P:(DE-He78)68d90eb013f51c689f9ebea83a920858
|b 5
|u dkfz
700 1 _ |a Alsina-Sanchis, Elisenda
|0 0000-0002-5761-632X
|b 6
700 1 _ |a Bohnenberger, Hanibal
|0 0000-0003-1038-1030
|b 7
700 1 _ |a Fernandez-Florido, Elena
|0 0000-0003-3034-5109
|b 8
700 1 _ |a Mülfarth, Ronja
|0 P:(DE-He78)3d2b0a3563ccf6bc6ee65cf2976efe5f
|b 9
700 1 _ |a Vacca, Margherita
|0 P:(DE-He78)db0b2f396de01b200ce18462ab29fdbc
|b 10
700 1 _ |a Gerwing, Jennifer
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Conradi, Lena-Christin
|b 12
700 1 _ |a Ströbel, Philipp
|b 13
700 1 _ |a Trumpp, Andreas
|0 P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2
|b 14
|u dkfz
700 1 _ |a Mogler, Carolin
|b 15
700 1 _ |a Fischer, Andreas
|0 P:(DE-He78)039283a5d51058ec79156d0ef67132da
|b 16
|u dkfz
700 1 _ |a Rodriguez-Vita, Juan
|0 0000-0001-9547-5508
|b 17
|e Last author
773 _ _ |a 10.1038/s41467-023-38064-w
|g Vol. 14, no. 1, p. 2353
|0 PERI:(DE-600)2553671-0
|n 1
|p 2353
|t Nature Communications
|v 14
|y 2023
|x 2041-1723
909 C O |o oai:inrepo02.dkfz.de:275610
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)b27922c32bcdf07ca4d5f13ecdcfd100
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)95d56cbcb8b1bb5783526d136049e3df
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)b3e23abb6bede16f11543cc21ae0feeb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 0000-0002-0690-9878
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)68d90eb013f51c689f9ebea83a920858
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 0000-0002-5761-632X
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 0000-0003-3034-5109
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)3d2b0a3563ccf6bc6ee65cf2976efe5f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)db0b2f396de01b200ce18462ab29fdbc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)039283a5d51058ec79156d0ef67132da
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 0000-0001-9547-5508
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2023
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-10-13T14:44:21Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-11
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2022-11-11
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2022-11-11
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:09:09Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2023-08-29
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
920 2 _ |0 I:(DE-He78)A270-20160331
|k A270
|l A270 Vaskuläre Signaltransduktion und Krebs
|x 0
920 0 _ |0 I:(DE-He78)A270-20160331
|k A270
|l A270 Vaskuläre Signaltransduktion und Krebs
|x 0
920 1 _ |0 I:(DE-He78)A270-20160331
|k A270
|l A270 Vaskuläre Signaltransduktion und Krebs
|x 0
920 1 _ |0 I:(DE-He78)A010-20160331
|k A010
|l A010 Stammzellen und Krebs
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A270-20160331
980 _ _ |a I:(DE-He78)A010-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21